HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jae-Kyo Jeong Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

5/2015Inhibition of the autophagy flux by gingerol enhances TRAIL-induced tumor cell death.
3/2015Induction of cellular prion protein (PrPc) under hypoxia inhibits apoptosis caused by TRAIL treatment.
11/2011Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.
3/2011Sulforaphane blocks hypoxia-mediated resistance to TRAIL-induced tumor cell death.
8/2010Hypoxia inducing factor-1alpha regulates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in tumor cells exposed to hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jae-Kyo Jeong Research Topics

Disease

17Prion Diseases (Transmissible Spongiform Encephalopathies)
06/2019 - 02/2010
16Neurodegenerative Diseases (Neurodegenerative Disease)
06/2019 - 02/2010
9Neoplasms (Cancer)
09/2018 - 08/2010
9Hypoxia (Hypoxemia)
02/2016 - 02/2010
8Mitochondrial Diseases (Mitochondrial Disease)
09/2018 - 03/2012
5Neuroblastoma
11/2014 - 02/2010
4Lung Neoplasms (Lung Cancer)
09/2018 - 05/2015
4Scrapie
08/2013 - 11/2011
3Obesity
11/2015 - 04/2012
3Alzheimer Disease (Alzheimer's Disease)
11/2014 - 10/2010
3Parkinson Disease (Parkinson's Disease)
10/2013 - 06/2012
1Body Weight (Weight, Body)
01/2019
1Osteosarcoma (Osteogenic Sarcoma)
01/2018
1Wounds and Injuries (Trauma)
01/2016
1Iron Overload
03/2015
1Colonic Neoplasms (Colon Cancer)
03/2015
1Carcinoma (Carcinomatosis)
01/2015
1Proteostasis Deficiencies
11/2014
1Huntington Disease (Huntington's Disease)
11/2014
1Adenocarcinoma
01/2014
1Multiple Sclerosis
12/2013
1Bone Resorption
04/2013
1Multiple Myeloma
04/2013
1Vascular Diseases (Vascular Disease)
04/2013
1Postmenopausal Osteoporosis
04/2013
1Inflammation (Inflammations)
12/2012
1Arthritis (Polyarthritis)
12/2012
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
03/2012
1Prostatic Neoplasms (Prostate Cancer)
11/2011
1Osteonecrosis (Kienbock's Disease)
09/2010
1Osteoporosis
09/2010

Drug/Important Bio-Agent (IBA)

13Prion ProteinsIBA
01/2019 - 02/2010
11PrionsIBA
06/2019 - 02/2010
8Protein Isoforms (Isoforms)IBA
12/2013 - 02/2010
7Proteins (Proteins, Gene)FDA Link
03/2015 - 03/2011
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2015 - 08/2010
4SilverIBA
02/2016 - 01/2014
4MelatoninIBA
08/2015 - 09/2012
4LigandsIBA
05/2015 - 08/2010
4TNF-Related Apoptosis-Inducing LigandIBA
03/2015 - 08/2010
4Neuroprotective AgentsIBA
10/2013 - 06/2012
3Small Interfering RNA (siRNA)IBA
01/2019 - 01/2013
3Antineoplastic Agents (Antineoplastics)IBA
09/2018 - 03/2015
3Diphosphonates (Bisphosphonates)IBA
01/2018 - 09/2010
2LipidsIBA
01/2019 - 12/2012
2ResveratrolIBA
09/2018 - 06/2012
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2018 - 11/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2016 - 11/2012
2Sphingosine-1-Phosphate ReceptorsIBA
11/2015 - 12/2012
2gingerolIBA
05/2015 - 08/2013
2Deferoxamine (Desferal)FDA LinkGeneric
03/2015 - 05/2012
2CateninsIBA
11/2014 - 10/2013
2Peptides (Polypeptides)IBA
12/2013 - 05/2012
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
12/2013 - 12/2012
2JNK Mitogen-Activated Protein KinasesIBA
12/2013 - 09/2010
2Pharmaceutical PreparationsIBA
04/2013 - 05/2011
2NitrogenIBA
04/2013 - 09/2010
2prion protein (106-126)IBA
05/2012 - 02/2010
2CholesterolIBA
03/2012 - 10/2010
2Caspase 3 (Caspase-3)IBA
03/2011 - 02/2010
1Antihypertensive Agents (Antihypertensives)IBA
06/2019
1Cytochromes c (Cytochrome c)IBA
09/2018
1Matrix Metalloproteinases (MMPs)IBA
09/2018
1ophiopogonin BIBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Chelating AgentsIBA
03/2015
1IronIBA
03/2015
1CaspasesIBA
03/2015
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2015
1SphingosineIBA
10/2014
1Phosphotransferases (Kinase)IBA
10/2014
1FTY 720PIBA
12/2013
1Fingolimod Hydrochloride (FTY720)FDA Link
12/2013
1ICG 001IBA
10/2013
1Bone Density Conservation AgentsIBA
04/2013
1LactoferrinIBA
02/2013
1Histone Deacetylases (Histone Deacetylase)IBA
01/2013
1Sirtuin 1IBA
01/2013
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2013
1Sp1 Transcription FactorIBA
12/2012
1InterleukinsIBA
12/2012
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2012
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2012
1Biological ProductsIBA
04/2012
1CytokinesIBA
11/2011
1UbiquitinIBA
11/2011
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2011
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2011
1sulforaphaneIBA
03/2011
1phenethyl isothiocyanate (PEITC)IBA
03/2011
1Gentian Violet (Violet, Crystal)FDA Link
09/2010
1Zoledronic Acid (Zometa)FDA Link
09/2010
1Risedronic Acid (Actonel)FDA LinkGeneric
09/2010
1bcl-X ProteinIBA
09/2010
1Alendronate (Alendronate Sodium)FDA LinkGeneric
09/2010

Therapy/Procedure

8Therapeutics
09/2018 - 08/2010
3Drug Therapy (Chemotherapy)
02/2016 - 08/2010
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2018
1Aftercare (After-Treatment)
02/2016
1Transplantation
12/2013